Literature DB >> 10910932

Wild-type HFE protein normalizes transferrin iron accumulation in macrophages from subjects with hereditary hemochromatosis.

G Montosi1, P Paglia, C Garuti, C A Guzman, J M Bastin, M P Colombo, A Pietrangelo.   

Abstract

Hereditary hemochromatosis (HC) is one of the most common single-gene hereditary diseases. A phenotypic hallmark of HC is low iron in reticuloendothelial cells in spite of body iron overload. Most patients with HC have the same mutation, a change of cysteine at position 282 to tyrosine (C282Y) in the HFE protein. The role of HFE in iron metabolism and the basis for the phenotypic abnormalities of HC are not understood. To clarify the role of HFE in the phenotypic expression of HC, we studied monocytes-macrophages from subjects carrying the C282Y mutation in the HFE protein and clinically expressing HC and transfected them with wild-type HFE by using an attenuated Salmonella typhimurium strain as a gene carrier. The Salmonella system allowed us to deliver genes of interest specifically to monocytes-macrophages with high transduction efficiency. The accumulation of (55)Fe delivered by (55)Fe-Tf was significantly lower in macrophages from patients with HC than from controls expressing wild-type HFE. Transfection of HC macrophages with the HFE gene resulted in a high level of expression of HFE protein at the cell surface. The accumulation of (55)Fe delivered by (55)Fe-Tf was raised by 40% to 60%, and this was reflected by an increase in the (55)Fe-ferritin pool within the HFE-transfected cells. These results suggest that the iron-deficient phenotype of HC macrophages is a direct effect of the HFE mutation, and they demonstrate a role for HFE in the accumulation of iron in these cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10910932

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  32 in total

1.  The haemochromatosis protein HFE induces an apparent iron-deficient phenotype in H1299 cells that is not corrected by co-expression of beta 2-microglobulin.

Authors:  Jian Wang; Guohua Chen; Kostas Pantopoulos
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

Review 2.  Molecular pathogenesis of iron overload.

Authors:  D Trinder; C Fox; G Vautier; J K Olynyk
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

3.  Pharmacogenetics of nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathy.

Authors:  Asha R Kallianpur; Todd Hulgan
Journal:  Pharmacogenomics       Date:  2009-04       Impact factor: 2.533

4.  Hereditary Hemochromatosis and Iron Metabolism.

Authors:  Joyce Carlson; Sigvard Olsson
Journal:  EJIFCC       Date:  2001-07-22

Review 5.  The relevance of the intestinal crypt and enterocyte in regulating iron absorption.

Authors:  Phillip S Oates
Journal:  Pflugers Arch       Date:  2007-05-01       Impact factor: 3.657

Review 6.  Manipulation of iron to determine survival: competition between host and pathogen.

Authors:  Nihay Laham; Rachel Ehrlich
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

7.  Function of the hemochromatosis protein HFE: Lessons from animal models.

Authors:  Kostas Pantopoulos
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

8.  Mechanisms of HFE-induced regulation of iron homeostasis: Insights from the W81A HFE mutation.

Authors:  An-Sheng Zhang; Paige S Davies; Hanqian L Carlson; Caroline A Enns
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-21       Impact factor: 11.205

9.  Duodenal HFE expression and hepcidin levels determine body iron homeostasis: modulation by genetic diversity and dietary iron availability.

Authors:  Susanne Ludwiczek; Igor Theurl; Erika Artner-Dworzak; Michael Chorney; Guenter Weiss
Journal:  J Mol Med (Berl)       Date:  2004-05-13       Impact factor: 4.599

Review 10.  HFE gene in primary and secondary hepatic iron overload.

Authors:  Giada Sebastiani; Ann-P Walker
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.